Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously

Infection and Immunity

Volumn 70, Issue 4, 2002, Pages 1874-1880

  Güereña Burgueño, Fernando ^a   Hall, Eric R ^a   Taylor, David N ^a   Cassels, Frederick J ^a   Scott, Daniel A ^a   Wolf, Marcia K ^a   Roberts, Zachary J ^a   Nesterova, Galina V ^a   Alving, Carl R ^a   Glenn, Gregory M ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CS6 ANTIGEN; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; DELAYED HYPERSENSITIVITY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODY-PRODUCING CELLS; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL PROTEINS; BACTERIAL TOXINS; DIARRHEA; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; MIDDLE AGED;

EID: 0036128539     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.4.1874-1880.2002     Document Type: Article

References (58)

1. Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood
2. Contact dermatitis in blacks
3. Improved detection of enterotoxigenic Escherichia coli among patients with travelers' diarrhea, by use of the polymerase chain reaction technique
4. Colonization factors of diarrheagenic E. coli and their intestinal receptors
5. Species specificity of in vitro Escherichia coli adherence to host intestinal cell membranes and its correlation with in vivo colonization and infectivity
6. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: Results of a large-scale field trial
7. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
8. The prospects for immunizing against Escherichia coli (ETEC)
9. A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells
10. Traveler's diarrhea at sea: Three outbreaks of waterborne enterotoxigenic Escherichia coli on cruise ships
11. The Signed-Rank (Wilcoxon) test in the rapid analysis of biological data
12. Milk immunoglobulin with specific activity against purified colonization factor antigens can protect against oral challenge with enterotoxigenic Escherichia coli
13. Skin immunization made possible by cholera toxin
14. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge
15. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants
16. Transcutaneous immunization: A human vaccine delivery strategy using a patch
17. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine
18. Transcutaneous immunization: T cell responses and boosting of existing immunity
19. Binding of enterotoxigenic Escherichia coli to isolated enterocytes and intestinal mucus
20. Antibody responses in humans against coli surface antigen 6 of enterotoxigenic Escherichia coli
21. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years
22. A waterborne outbreak of gastroenteritis in the Golan Heights due to enterotoxigenic Escherichia coli
23. Diarrheal disease during Operation Desert Shield
24. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine
25. Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine
26. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease
27. Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997
28. Ensuring vaccine safety in immunization programmes - A W. H. O. perspective
29. Adhesion of enterotoxigenic Escherichia coli in humans and animals
30. Travellers' diarrhoea: Prospects for successful immunoprophylaxis
31. Immunity to enterotoxigenic Escherichia coli
32. The mechanism of cholera toxin adjuvanticity
33. Seasonal variation in etiology of travelers' diarrhea
34. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
35. Treatment of traveler's diarrhea
36. Protection against experimental cholera by antitoxin
37. Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization
38. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children
39. Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli
40. On analysis of epidemiological data involving a 2 × 2 contingency table: An overview of Fisher's exact test and Yates' correction for continuity
41. Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults
42. Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: Results of the initial evaluaton in children
43. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants
44. Diarrheagenic Escherichia coli and acute and persistent diarrhea in returned travelers
45. Norfloxacin for the prophylaxis of travelers' diarrhea in U. S. military personnel
46. Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area
47. Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli
48. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli
49. Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres
50. Polymicrobial aetiology of travellers' diarrhoea
51. Epidemiology of foodborne diseases: A worldwide review
52. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam
53. Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine
54. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli
55. The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunits
56. Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East
57. Antimicrobial resistance of gram-negative bacteria isolated from foods in Mexico
58. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli